These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2574571)

  • 1. Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.
    Brömme D; Schierhorn A; Kirschke H; Wiederanders B; Barth A; Fittkau S; Demuth HU
    Biochem J; 1989 Nov; 263(3):861-6. PubMed ID: 2574571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.
    Brömme D; Neumann U; Kirschke H; Demuth HU
    Biochim Biophys Acta; 1993 Oct; 1202(2):271-6. PubMed ID: 8399390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective inactivation of proteinases with N-peptidyl-O-acylhydroxylamines.
    Demuth HU; Schönlein C; Barth A
    Biochim Biophys Acta; 1989 Jun; 996(1-2):19-22. PubMed ID: 2660912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidylpeptidase IV--inactivation with N-peptidyl-O-aroyl hydroxylamines.
    Demuth HU; Baumgrass R; Schaper C; Fischer G; Barth A
    J Enzyme Inhib; 1988; 2(2):129-42. PubMed ID: 2906996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases.
    Demuth HU; Schierhorn A; Bryan P; Höfke R; Kirschke H; Brömme D
    Biochim Biophys Acta; 1996 Jul; 1295(2):179-86. PubMed ID: 8695644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-peptidyl-O-carbamoyl amino acid hydroxamates: irreversible inhibitors for the study of the S2' specificity of cysteine proteinases.
    Brömme D; Kirschke H
    FEBS Lett; 1993 May; 322(3):211-4. PubMed ID: 8486151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.
    Darkins P; Gilmore BF; Hawthorne SJ; Healy A; Moncrieff H; McCarthy N; McKervey MA; Brömme D; Pagano M; Walker B
    Chem Biol Drug Des; 2007 Mar; 69(3):170-9. PubMed ID: 17441903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inactivation of cathepsins S and L by peptidyl (acyloxy)methyl ketones.
    Brömme D; Smith RA; Coles PJ; Kirschke H; Storer AC; Krantz A
    Biol Chem Hoppe Seyler; 1994 May; 375(5):343-7. PubMed ID: 8074807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N,O-diacylhydroxylamines as enzyme-activated inhibitors for serine proteases.
    Fischer G; Demuth HU; Barth A
    Pharmazie; 1983 Apr; 38(4):249-50. PubMed ID: 6346347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proteases with enkephalin-analogue inhibitors.
    Demuth HU; Silberring J; Nyberg F
    J Enzyme Inhib; 1991; 4(4):289-98. PubMed ID: 1669830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dynorphin converting enzymes from human spinal cord by N-peptidyl-O-acyl hydroxylamines.
    Silberring J; Demuth HU; Brostedt P; Nyberg F
    J Biochem; 1993 Nov; 114(5):648-51. PubMed ID: 8113215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of regulation of activity of lysosomal thiol proteinases in the thyroid gland: effects of protein synthesis inhibitors].
    Stroev EA; Kochukov MIu
    Biull Eksp Biol Med; 1997 May; 123(5):521-3. PubMed ID: 9264701
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin.
    Nicklin MJ; Barrett AJ
    Biochem J; 1984 Oct; 223(1):245-53. PubMed ID: 6388564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions between dipeptidyl peptidase IV and diacyl hydroxylamines: mechanistic investigations.
    Demuth HU; Neumann U; Barth A
    J Enzyme Inhib; 1989; 2(4):239-48. PubMed ID: 2566666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
    Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide methyl ketones as reversible inhibitors of cysteine proteinases.
    Brömme D; Bartels B; Kirschke H; Fittkau S
    J Enzyme Inhib; 1989; 3(1):13-21. PubMed ID: 2487320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
    Wikstrom P; Kirschke H; Stone S; Shaw E
    Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B.
    Smith RA; Coles PJ; Spencer RW; Copp LJ; Jones CS; Krantz A
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1201-6. PubMed ID: 3178802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.
    Demuth HU; Schlenzig D; Schierhorn A; Grosche G; Chapot-Chartier MP; Gripon JC
    FEBS Lett; 1993 Mar; 320(1):23-7. PubMed ID: 8096464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of specificity and inhibition of human cerebrospinal fluid dynorphin converting enzyme.
    Demuth HU; Nyberg F
    J Enzyme Inhib; 1991; 4(4):299-306. PubMed ID: 1688305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.